Patent · US Active

Antibodies to IL-17A

US8193319B2 · kind B2 · utility

1Cited by
2References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 27, 2010
Grant dateJun 5, 2012
Priority date—
Expiry dateOct 27, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Engineered antibodies to human IL-17A are provided, as well as uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.